Publicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (16)

2024

  1. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  2. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 215-225

2023

  1. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  2. Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study

    American Heart Journal, Vol. 264, pp. 72-82

2022

  1. Bioactive or Drug-Eluting Stents in 75 Years or Older Patients: The BIODES-75 Registry

    Cardiovascular Revascularization Medicine, Vol. 42, pp. 114-120

  2. Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial

    Journal of the American Heart Association, Vol. 11, Núm. 23

  3. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

    PLoS ONE, Vol. 17, Núm. 12 December

  4. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973

2021

  1. 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction

    Journal of the American College of Cardiology, Vol. 77, Núm. 9, pp. 1165-1178

  2. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation

    Journal of cardiovascular pharmacology, Vol. 78, Núm. 3, pp. 463-473

  3. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol

    PLoS ONE, Vol. 16, Núm. 7 July

  4. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

  2. Transcatheter Aortic Valve Replacement for Residual Lesion of the Aortic Valve Following “Healed” Infective Endocarditis

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 17, pp. 1983-1996

2019

  1. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 1, pp. 22-32

2017

  1. Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR)

    Clinical Cardiology, Vol. 40, Núm. 8, pp. 580-585